Login / Signup

Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer.

Shu-Kui QinRui-Hua XuLin ShenJianming XuYuxian BaiLei YangYanhong DengZhen-Dong ChenHaijun ZhongHongming PanWeijian GuoYongqian ShuYing YuanJianfeng ZhouNong XuTian-Shu LiuDong MaChangping WuYing ChengDonghui ChenWei LiSan-Yuan SunZhuang YuPeiguo CaoHaihui ChenJiejun WangShubin WangHongbing WangNing WangBin ZhangQiang ZhangWeiguo SuXiaojun GuoJin Li
Published in: OncoTargets and therapy (2021)
NCT02314819.
Keyphrases
  • metastatic colorectal cancer
  • phase iii
  • healthcare
  • clinical trial
  • palliative care
  • open label
  • study protocol
  • phase ii
  • quality improvement
  • double blind
  • randomized controlled trial
  • pain management